Skip to main content

Currently Enrolling

You Deserve the Best in Advanced Orthopedic Care

You may qualify for one of our clinical trials! For more information about joining a clinical trial, please email research@sourcehealthcare.com or call (310) 574-2777 ext. 3.

Clinical Trials for Orthopedic Pain

CURRENTLY RECRUITING

Mesoblast - Phase III Clinical Trial for Degenerative Disc Disease and Low Back Pain

This is a Phase 3 clinical trial of the investigational drug REXLEMESTROCEL-L combined with Hyaluronic Acid for the treatment of Lumbar Degenerative Disc Disease. REXLEMESTROCEL-L (Mesenchymal Precursor Cells) + 1% Hyaluronic Acid are administered by an injection into the spinal disc. Possible benefits include the reduction of pain-related disability associated with degenerative disc disease. This study involves a minimum of 7 visits to our site over the course of 24 months and includes a stipend for each follow-up visit.

Learn more about Disc Degeneration >>
Learn more about this study >>
Learn more about this trial >>

ENROLL

CURRENTLY RECRUITING

BioRestorative - Phase II Clinical Trial for Degenerative Disc Disease and Low Back Pain

This is a Phase 2 clinical trial of the investigational drug BRTX-100 (autologous hypoxic-cultured Mesenchymal Precursor Cells from bone marrow + autologous platelet lysate (APL) ) for the treatment of Lumbar Degenerative Disc Disease. BRTX-100 administered by an injection into the spinal disc. Possible benefits include the reduction of pain-related disability associated with degenerative disc disease. This study involves a minimum of 7 visits to our site over the course of 24 months and includes a stipend for each visit.

Learn more about Disc Degeneration >>
Learn more about this study >>
Learn more about this trial >>

ENROLL

Schedule a
Consultation

DIRECTIONS 310-574-2777
Contact Us
close slider

    SEND US A MESSAGE